These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7575725)

  • 21. In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model.
    Pelletier JP; Martel-Pelletier J
    J Rheumatol Suppl; 1991 Feb; 27():127-30. PubMed ID: 2027112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes.
    Pelletier JP; Fernandes JC; Brunet J; Moldovan F; Schrier D; Flory C; Martel-Pelletier J
    Arthritis Rheum; 2003 Jun; 48(6):1582-93. PubMed ID: 12794826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: Immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage.
    Kammermann JR; Kincaid SA; Rumph PF; Baird DK; Visco DM
    Osteoarthritis Cartilage; 1996 Mar; 4(1):23-34. PubMed ID: 8731393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis.
    Pelletier JP; Martel-Pelletier J
    Arthritis Rheum; 1989 Feb; 32(2):181-93. PubMed ID: 2920053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway.
    DiBattista JA; Martel-Pelletier J; Fujimoto N; Obata K; Zafarullah M; Pelletier JP
    Lab Invest; 1994 Aug; 71(2):270-8. PubMed ID: 8078306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor.
    Pelletier J; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
    Osteoarthritis Cartilage; 1999 Jul; 7(4):416-8. PubMed ID: 10419785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
    Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
    Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study.
    Pelletier JP; Faure MP; DiBattista JA; Wilhelm S; Visco D; Martel-Pelletier J
    Am J Pathol; 1993 Jan; 142(1):95-105. PubMed ID: 8424468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose prednisone treatment does not reduce the severity of osteoarthritis in dogs after anterior cruciate ligament transection.
    Myers SL; Brandt KD; O'Connor BL
    J Rheumatol; 1991 Dec; 18(12):1856-62. PubMed ID: 1795325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.
    van Dalen SC; Blom AB; Slöetjes AW; Helsen MM; Roth J; Vogl T; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; van den Bosch MH; van Lent PL
    Osteoarthritis Cartilage; 2017 Mar; 25(3):385-396. PubMed ID: 27654963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage.
    Pelletier JP; Martel-Pelletier J
    Drugs; 1993; 46 Suppl 1():34-9. PubMed ID: 7506192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis.
    Pelletier JP; Martel-Pelletier J; Ghandur-Mnaymneh L; Howell DS; Woessner JF
    Arthritis Rheum; 1985 May; 28(5):554-61. PubMed ID: 2988573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis.
    Pelletier JP; Mineau F; Faure MP; Martel-Pelletier J
    Arthritis Rheum; 1990 Oct; 33(10):1466-76. PubMed ID: 2171538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction.
    Roy-Beaudry M; Martel-Pelletier J; Pelletier JP; M'Barek KN; Christgau S; Shipkolye F; Moldovan F
    Arthritis Rheum; 2003 Oct; 48(10):2855-64. PubMed ID: 14558091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
    Manicourt DH; Altman RD; Williams JM; Devogelaer JP; Druetz-Van Egeren A; Lenz ME; Pietryla D; Thonar EJ
    Arthritis Rheum; 1999 Jun; 42(6):1159-67. PubMed ID: 10366108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency.
    Behets C; Williams JM; Chappard D; Devogelaer JP; Manicourt DH
    J Bone Miner Res; 2004 Nov; 19(11):1821-6. PubMed ID: 15476582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
    Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
    Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of tenidap on cartilage integrity in vitro.
    Dingle JT; Leeming MR; Martindale JJ
    Ann Rheum Dis; 1993 Apr; 52(4):292-9. PubMed ID: 8484696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes.
    Boileau C; Martel-Pelletier J; Brunet J; Tardif G; Schrier D; Flory C; El-Kattan A; Boily M; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):488-500. PubMed ID: 15693013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline.
    Yu LP; Smith GN; Brandt KD; Myers SL; O'Connor BL; Brandt DA
    Arthritis Rheum; 1992 Oct; 35(10):1150-9. PubMed ID: 1329773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.